RxDoctor Payments Data

Paul Sousa, MD

Adult Reconstructive Orthopaedic Surgery · Buckeye, AZNPI 1275915332

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (48.5%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 82.6% of it on its own, with 10 other manufacturers making up the rest. 2025 is the largest year on record at $48,472, more than ten times the $1,877 reported in 2019.

$69,836in general payments, 2019–2025

Across 137 payments — averaging $509.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$58K
  • Zimmer Biomet$9K
  • Medical Device Business Services, Inc.$1K
  • Stryker$1K
  • Davol Inc.$274
  • Onkos Surgical, Inc.$161
  • plus $410 from 5 others

What the payments were for

  • Consulting fees$33,86348%
  • Speaking & faculty fees$11,55017%
  • Travel & lodging$8,56612%
  • Food & beverage$8,13312%
  • Education$7,72411%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$69,836 in reported general payments places this provider in the 85th percentile of 43 adult reconstructive orthopaedic surgery providers in Arizona.

See all adult reconstructive orthopaedic surgery providers in Arizona

Medicare billing

Part B allowed, 2024
$702,712
Medicare patients
1,093
Services billed
11,878

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib324$7,001
Oxycodone Hcl123$921
Diclofenac Sodium53$788
Amoxicillin498$653
Meloxicam238$576
Gabapentin11$135
Tramadol Hcl45$132
Clindamycin Hcl81$130
Ibuprofen28$125
Methylprednisolone16$100
Ondansetron Hcl11$63

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Buckeye

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →